Free Trial
OTCMKTS:OCPNY

Olympus (OCPNY) Stock Price, News & Analysis

Olympus logo
$18.00 -0.25 (-1.37%)
As of 01/31/2023

About Olympus Stock (OTCMKTS:OCPNY)

Key Stats

Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$16.80
$74.99
Volume
400 shs
Average Volume
860,265 shs
Market Capitalization
$23.15 billion
P/E Ratio
21.95
Dividend Yield
0.44%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Receive OCPNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.

OCPNY Stock News Headlines

Secure this "AI Fuel" Stock Before the Billionaires Buy It All
The Washington Post says America is running out of a key material needed for AI—and without it, companies like NVIDIA could be forced to shut down. While billionaires like Buffett and Gates scramble to secure access, one under-the-radar firm has quietly locked up supply. Bloomberg even calls it a “monopoly.” And it’s still trading near $20.
See More Headlines

OCPNY Stock Analysis - Frequently Asked Questions

Olympus' stock was trading at $18.00 at the beginning of 2025. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00.
View the best growth stocks for 2025 here
.

Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings data on Thursday, August, 5th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.03. The company earned $1.75 billion during the quarter, compared to analyst estimates of $1.49 billion. Olympus had a trailing twelve-month return on equity of 24.30% and a net margin of 13.80%.

The following companies are subsidiaries of Olympus: FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and more.

Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2021
Today
5/17/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Structural clay products
Sub-Industry
N/A
Current Symbol
OTCMKTS:OCPNY
CIK
N/A
Employees
31,557
Year Founded
1919

Profitability

Trailing P/E Ratio
21.95
Forward P/E Ratio
10.91
P/E Growth
1.07
Net Income
$1.03 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.74 billion
Cash Flow
$1.22 per share
Price / Cash Flow
14.76
Book Value
$3.50 per share
Price / Book
5.14

Miscellaneous

Outstanding Shares
1,285,890,000
Free Float
N/A
Market Cap
$23.15 billion
Optionable
Not Optionable
Beta
0.70

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:OCPNY) was last updated on 5/18/2025 by MarketBeat.com Staff
From Our Partners